News

A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health care costs for patients with cancer.

Study findings suggest that older patients with MCL may not benefit from maintenance rituximab due to an inability to tolerate this treatment.

Study findings suggest Medicaid expansion was associated with subsequent diagnosis and treatment outcomes for genitourinary malignant neoplasms, and may reduce socioeconomic disparities.

A recent study examining ibrutinib combinations in CLL found that ibrutinib plus venetoclax may provide high complete response rates and, importantly, high rates of undetectable MRD.

Study findings show the implementation of clinical care pathways resulted in improved survival for patients diagnosed with NSCLC.